FGF21
Fibroblast growth factor 21
Also known as: FGF21_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NSA1
- Gene
- FGF21
- Ensembl
- ENSG00000105550
- Chromosome
- 19
- Canonical length
- 209 aa
- Protein class
- Predicted secreted proteins, RAS pathway related proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
Theis gene encodes a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities and are involved in a variety of biological processes. This protein is a secreted endocrine factor that functions as a major metabolic regulator. The encoded protein stimulates the uptake of glucose in adipose tissue. [provided by RefSeq, Mar 2016]
Canonical amino-acid sequenceUniProt
209 residues, UniProt reviewed canonical sequence.
>Q9NSA1|FGF21
1 MDSDETGFEH SGLWVSVLAG LLLGACQAHP IPDSSPLLQF GGQVRQRYLY TDDAQQTEAH
61 LEIREDGTVG GAADQSPESL LQLKALKPGV IQILGVKTSR FLCQRPDGAL YGSLHFDPEA
121 CSFRELLLED GYNVYQSEAH GLPLHLPGNK SPHRDPAPRG PARFLPLPGL PPALPEPPGI
181 LAPQPPDVGS SDPLSMVGPS QGRSPSYASLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FGF21 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 79 nTPM
Expression across tissuesHPA
Tissue
- liver: 79 nTPM
- skeletal muscle: 0.7 nTPM
- pancreas: 0.4 nTPM
- cerebellum: 0.1 nTPM
- thyroid gland: 0.1 nTPM
- adipose tissue: 0 nTPM
Single-cell type
- hepatocytes: 7.7 nCPM
- cholangiocytes: 2 nCPM
- early spermatids: 0.1 nCPM
- goblet cells: 0.1 nCPM
- migrating cytotrophoblasts: 0.1 nCPM
- myonuclei: 0.1 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.3
- gnomAD pLI
- 0.03
- gnomAD missense Z
- -0.3
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell-cell signaling
- fibroblast growth factor receptor signaling pathway
- neurogenesis
- positive regulation of cell population proliferation
- positive regulation of cold-induced thermogenesis
- positive regulation of D-glucose import
- positive regulation of ERK1 and ERK2 cascade
- positive regulation of MAPK cascade
- positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway
- regulation of cell migration
- regulation of low-density lipoprotein particle clearance
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FGF21 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FGF21 as an antibody target. Whether an autoantibody or antibody against FGF21 could matter depends on whether native FGF21 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FGF21 is annotated as secreted, so native FGF21 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label FGF21 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...